Your browser doesn't support javascript.
loading
Sequential fate-switches in stem-like cells drive the tumorigenic trajectory from human neural stem cells to malignant glioma.
Wang, Xiaofei; Zhou, Ran; Xiong, Yanzhen; Zhou, Lingling; Yan, Xiang; Wang, Manli; Li, Fan; Xie, Chuanxing; Zhang, Yiming; Huang, Zongyao; Ding, Chaoqiong; Shi, Kaidou; Li, Weida; Liu, Yu; Cao, Zhongwei; Zhang, Zhen-Ning; Zhou, Shengtao; Chen, Chong; Zhang, Yan; Chen, Lu; Wang, Yuan.
Afiliación
  • Wang X; Department of Neurology and Department of Neurosurgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and National Collaborative Innovation Center, Chengdu, Sichuan, 610041, China.
  • Zhou R; Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
  • Xiong Y; Department of Neurology and Department of Neurosurgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and National Collaborative Innovation Center, Chengdu, Sichuan, 610041, China.
  • Zhou L; National Clinical Research Center for Geriatrics, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
  • Yan X; Department of Neurology and Department of Neurosurgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and National Collaborative Innovation Center, Chengdu, Sichuan, 610041, China.
  • Wang M; Department of Neurology and Department of Neurosurgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and National Collaborative Innovation Center, Chengdu, Sichuan, 610041, China.
  • Li F; Department of Hematology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
  • Xie C; Department of Neurology and Department of Neurosurgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and National Collaborative Innovation Center, Chengdu, Sichuan, 610041, China.
  • Zhang Y; Department of Neurology and Department of Neurosurgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and National Collaborative Innovation Center, Chengdu, Sichuan, 610041, China.
  • Huang Z; Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
  • Ding C; Department of Neurology and Department of Neurosurgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and National Collaborative Innovation Center, Chengdu, Sichuan, 610041, China.
  • Shi K; Department of Neurology and Department of Neurosurgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and National Collaborative Innovation Center, Chengdu, Sichuan, 610041, China.
  • Li W; Department of Hematology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
  • Liu Y; Institute of Regenerative Medicine, Shanghai East Hospital, Tongji University, Shanghai, 200092, China.
  • Cao Z; Department of Hematology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
  • Zhang ZN; Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
  • Zhou S; Institute of Regenerative Medicine, Shanghai East Hospital, Tongji University, Shanghai, 200092, China.
  • Chen C; Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
  • Zhang Y; Department of Hematology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
  • Chen L; National Clinical Research Center for Geriatrics, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. yanzhang@scu.edu.cn.
  • Wang Y; Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. luchen@scu.edu.cn.
Cell Res ; 31(6): 684-702, 2021 06.
Article en En | MEDLINE | ID: mdl-33390587

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Glioblastoma / Células-Madre Neurales / Glioma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cell Res Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Glioblastoma / Células-Madre Neurales / Glioma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cell Res Año: 2021 Tipo del documento: Article País de afiliación: China